PHC Holdings

SciMed (Asia) Pte Ltd. is a Singapore-based company that specializes in the distribution of laboratory equipment and supplies, including cleanroom products, cell culture media, antibodies, and immunoassays. Established in 1992, the company serves various sectors such as agriculture, biopharmaceuticals, education, healthcare, industrial laboratories, medical devices, pharmaceuticals, and research life sciences. In addition to providing a comprehensive range of laboratory instruments and reagents, SciMed (Asia) offers biodecontamination and scientific services to support clients in meeting their research and scientific needs. As of July 2020, it operates as a subsidiary of PHC Holdings Corporation.

Lunaphore is a biotechnology company that specializes in advanced tumor analysis through its innovative microfluidic chip technology. This platform enables the rapid extraction of spatial proteomic and transcriptome data from tumors and other tissues, transforming standard assays into multiplex spatial biology applications with a user-friendly interface. Lunaphore's solutions support researchers in fields such as immunology, immuno-oncology, and neurology, facilitating the identification of clinically relevant biomarker signatures. By streamlining the cancer diagnostic process, Lunaphore enhances the efficiency and precision of laboratory and hospital assays, ultimately contributing to improved patient outcomes and advancing therapeutic development.

Lunaphore is a biotechnology company that specializes in advanced tumor analysis through its innovative microfluidic chip technology. This platform enables the rapid extraction of spatial proteomic and transcriptome data from tumors and other tissues, transforming standard assays into multiplex spatial biology applications with a user-friendly interface. Lunaphore's solutions support researchers in fields such as immunology, immuno-oncology, and neurology, facilitating the identification of clinically relevant biomarker signatures. By streamlining the cancer diagnostic process, Lunaphore enhances the efficiency and precision of laboratory and hospital assays, ultimately contributing to improved patient outcomes and advancing therapeutic development.

Aiforia Technologies, established in 2013 as a spin-off from the University of Helsinki's Finnish Institute for Molecular Medicine, specializes in cloud-based microscopy and pathology solutions driven by deep learning AI and high-performance computing. The company assists pathologists and scientists in efficiently analyzing medical images across various fields such as oncology and neuroscience, enabling accurate diagnoses and facilitating new discoveries.

Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems for individuals with diabetes. Founded in 1996, the company focuses on innovative and long-term implantable glucose monitoring solutions that utilize advanced fluorescence sensing technology. Its flagship products, Eversense and Eversense XL, are implantable CGM systems designed to monitor glucose levels for up to 90 and 180 days, respectively. These products aim to provide users with a reliable and stable means of glucose management, enhancing their ability to live confidently and manage their diabetes effectively. The majority of Senseonics' revenue comes from international markets, reflecting its strong presence in Europe.

Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems for individuals with diabetes. Founded in 1996, the company focuses on innovative and long-term implantable glucose monitoring solutions that utilize advanced fluorescence sensing technology. Its flagship products, Eversense and Eversense XL, are implantable CGM systems designed to monitor glucose levels for up to 90 and 180 days, respectively. These products aim to provide users with a reliable and stable means of glucose management, enhancing their ability to live confidently and manage their diabetes effectively. The majority of Senseonics' revenue comes from international markets, reflecting its strong presence in Europe.

Lunaphore is a biotechnology company that specializes in advanced tumor analysis through its innovative microfluidic chip technology. This platform enables the rapid extraction of spatial proteomic and transcriptome data from tumors and other tissues, transforming standard assays into multiplex spatial biology applications with a user-friendly interface. Lunaphore's solutions support researchers in fields such as immunology, immuno-oncology, and neurology, facilitating the identification of clinically relevant biomarker signatures. By streamlining the cancer diagnostic process, Lunaphore enhances the efficiency and precision of laboratory and hospital assays, ultimately contributing to improved patient outcomes and advancing therapeutic development.

KAKEHASHI Inc. is a Tokyo-based company established in 2016 that specializes in developing software as a service (SaaS) applications tailored for health insurance claim and drug history management, specifically designed for dispensing pharmacists using iPads. The company's mission is to bridge the gap between medical treatment and patients, aiming to enhance the healthcare landscape in Japan, which is known for its advanced medical technology and systems. As Japan faces a rapidly aging population, with projections indicating that by 2060, a significant portion of the population will be over 65, KAKEHASHI is committed to innovating healthcare solutions that support and improve the quality of life for this demographic, thereby contributing to the future of medical care in the country.

Ascensia Diabetes Care Holdings AG, based in Basel, Switzerland, is a global company focused on improving the lives of individuals with diabetes. The company specializes in the development and manufacture of blood glucose monitoring systems, lancing devices, and diabetes management software. By providing innovative healthcare devices, Ascensia aims to empower patients to take control of their health and enhance their overall well-being. Since its establishment, it has operated as a subsidiary of Panasonic Healthcare Holdings Co., Ltd.

Millennial Net's flagship platform, MeshScape, offers highly scalable, low power, reliable wireless mesh networking capability that is beyond any conventional WSN technologies. Millennial Net also provides Wireless Energy Management and Energy Efficiency solutions focused on commercial and public building applications. Typically save 15%-30% of a buildings current energy consumption.